http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RO-128602-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27b53625f941ba5f42dabc0e1760bd81 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-54 |
| filingDate | 2010-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79c034c6f63df919ad4aee7c114888d5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5020e990d6ec039d96cd5e06971b9e4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_131e9671ccceceb44cbcb55806772bb7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87d1bf75ecced6bed86da1a40d711e77 |
| publicationDate | 2013-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RO-128602-A2 |
| titleOfInvention | SEMISOLIDE PHARMACEUTICAL FORM WITH HYDROFIL TYPE LOCAL ADMINISTRATION CONTAINING COMBINATION OF OXICAMIC ORGANIC LIQUIDS |
| abstract | The invention relates to a pharmaceutical composition having antiinflammatory action. According to the invention, the composition consists of hydrophilic macromolecular compounds of the type of cellulose derivatives containing 0.1 ... 10% of copper complexes with non-steroidal anti-inflammatory agents, oxicam type, 1-5% stabilizing agents, 1. .5% hydrophilic absorption promoters and 5 ... 20% volatile alcohol components. |
| priorityDate | 2010-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 30.